Novartis receives EU approval for Cosentyx label update

Novartis said that the Committee for Medicinal Products for Human Use has approved a label update for Cosentyx, the first interleukin-17A approved to treat psoriasis.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news